Resources
Proteomics Databases
Metabolomics Databases

-
• Why Intact Mass Analysis Can Miss Minor Variants
Learn why intact mass analysis can miss minor variants in biologics, including resolution limits, low abundance, and deconvolution issues, plus practical steps to improve detection.
-
• When Targeted Mass Spectrometry Outperforms Discovery
Learn when targeted mass spectrometry outperforms discovery profiling for fixed-panel quantitation, cohort validation, selective MRM or PRM acquisition, and QC reporting.
-
• What Affects Targeted Proteomics Project Costs?
Learn what affects targeted proteomics project costs, including panel size, sample matrix, MRM or PRM platform, assay development, sample number, and reporting depth.
-
• What Affects Parallel Reaction Monitoring Costs?
Learn what drives parallel reaction monitoring cost, including assay development, isolation windows, panel size, matrix complexity, cohort size, and reporting before requesting a quote.
-
• What Affects AQUA Peptide Assay Development Costs?
Learn what drives AQUA peptide assay development cost, including synthesis, labeling, calibration design, matrix validation, panel size, and reporting before requesting a quote.
-
• What Affects Absolute Protein Quantification Costs?
Learn what affects absolute protein quantification costs, including AQUA standard design, calibration scope, sample matrix, MRM or PRM platform, and QC reporting depth.
-
• Targeted Proteomics vs Discovery Proteomics
Compare targeted proteomics and discovery proteomics by scientific question, acquisition strategy, coverage, and study stage to choose the right quantitative workflow.
-
• Targeted Proteomics: Principles and Research Uses
Learn targeted proteomics principles, including MRM and PRM workflows, technical advantages, limits, and research uses in biomarker and pathway quantitation.
-
• Scoping a Targeted Proteomics Project: Panel Size, Sample Matrix, and Validation Deliverables
Plan a targeted proteomics project with clear panel size, sample matrix, platform choice, and validation deliverables. Avoid assay rework and scope mismatches.
-
Compare targeted proteomics with MRM, PRM, and label-free discovery. Match the route to biomarker validation, pathway panels, and study stage.
How to order?
